Private Trust Co. NA Sells 131 Shares of Agilent Technologies, Inc. $A

Private Trust Co. NA reduced its position in Agilent Technologies, Inc. (NYSE:A) by 9.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,275 shares of the medical research company’s stock after selling 131 shares during the quarter. Private Trust Co. NA’s holdings in Agilent Technologies were worth $150,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of A. Brighton Jones LLC increased its holdings in Agilent Technologies by 6.1% in the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after buying an additional 270 shares during the period. GAMMA Investing LLC increased its holdings in Agilent Technologies by 34.6% in the 1st quarter. GAMMA Investing LLC now owns 5,362 shares of the medical research company’s stock valued at $627,000 after buying an additional 1,379 shares during the period. Wealth Enhancement Advisory Services LLC increased its holdings in Agilent Technologies by 86.3% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 51,363 shares of the medical research company’s stock valued at $6,009,000 after buying an additional 23,800 shares during the period. Blue Trust Inc. increased its holdings in Agilent Technologies by 8.0% in the 1st quarter. Blue Trust Inc. now owns 1,763 shares of the medical research company’s stock valued at $206,000 after buying an additional 131 shares during the period. Finally, Oppenheimer Asset Management Inc. grew its holdings in shares of Agilent Technologies by 2.4% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 47,918 shares of the medical research company’s stock valued at $5,605,000 after purchasing an additional 1,110 shares during the last quarter.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on A shares. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday, October 3rd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Agilent Technologies in a report on Wednesday, October 8th. TD Cowen lifted their price target on shares of Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a report on Tuesday, October 14th. Barclays lifted their price target on shares of Agilent Technologies from $125.00 to $150.00 and gave the company an “equal weight” rating in a report on Thursday, October 2nd. Finally, Robert W. Baird lifted their price target on shares of Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a report on Thursday, August 28th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $149.62.

Agilent Technologies Trading Up 2.0%

A opened at $145.79 on Wednesday. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. The firm has a market capitalization of $41.33 billion, a price-to-earnings ratio of 34.22, a PEG ratio of 4.67 and a beta of 1.26. The company’s 50 day moving average price is $128.72 and its two-hundred day moving average price is $118.37.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The firm had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period in the previous year, the firm posted $1.32 EPS. The company’s revenue for the quarter was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, research analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be given a $0.248 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s payout ratio is 23.24%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.